Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.
Stephen Murphy, PhD
Advertisement
Articles by Stephen Murphy, PhD
Advertisement
Latest Updated Articles
- Projected US Savings From Biosimilars, 2021-2025
Published: January 3rd 2022 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Trump Administration Flags Potential Link Between Prenatal Acetaminophen Use, Autism
2
Designing Value-Based Care Programs Around Arrhythmias
3
Final Thoughts on Arrhythmia Management
4
The Utility of Implantable Cardiac Rhythm Monitors
5
